Chemotherapy for Patients With Cancer of the Stomach
Status:
Completed
Trial end date:
2015-12-17
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine maximal tolerable dose (MTD) of the combination of
docetaxel, oxaliplatin and S1 (DOS) to patients with gastric cancer.